What happened at our partners… February 2024 edition

Applications for StartUp Research NOVA 2024, a collaborative post-graduation by ITQB NOVA and NOVA SBE, are open until April 19th, and several scholarships are available. The program, running from May 2nd to July 19th, provides entrepreneurial skills to life sciences researchers with a practical, hands-on learning approach covering innovation in biotech, intellectual property protection, project management, and more. On March 15th, LS4FUTURE will be holding an informative LS4FUTURE session about the program.

More information here.


Applications open for the Gulbenkian PhD Programme: the call is open until 29 March 2024; this year, the IBB program will receive up to 8 students. All selected students receive a fellowship from the Fundação Calouste Gulbenkian, renewable annually for four years. The program will start on 02/09/2024.

More information and applications here.


On February 5th, Bayer representatives visited iBET. Daniel Simão, Head of the Bayer Satellite Lab at iBET, and Pedro Cruz, iBET’s CTOO, provided insights into iBET and the Bayer Satellite Lab’s R&D initiatives. The visit emphasised the ongoing and robust collaboration between these two entities, and how this long-term partnership holds promising prospects for the future.

More information here.



NOVA Medical School welcomes 19 students from the Health Innovation specialisation of NOVA SBE’s Innovation and Entrepreneurship Master’s Degree 2023-2024, who now have NOVA Medical School as their second home. These students will have theoretical training with the lecturers – Medicine 4.0, and Nutrition or Ageing – but also practical training through the guidance of their master’s projects. This innovative initiative aims to train young adults worldwide in innovation and entrepreneurship in the health sector by giving them the skills of business, regulatory and health knowledge. It’s a pilot project – HealthEConnect – funded by the European Commission and with partners Nova SBE, NOVA Medical School, Copenhagen Business School, Patient Innovation, Startup Europe Regions Network and the BioInnovation Institute in Denmark.

Learn more here.